Molecular Cytogenetics Market Size, Share, Growth Analysis, By Product (Kits & Reagents, Testing Kits), By Technique (Comparative Genomic Hybridization), By Application (Genetic Disorders), By End User (Clinical & Research Laboratories), By Region - Industry Forecast 2024-2031

Global Molecular Cytogenetics Market size was valued at USD 2.37 billion in 2022 and is poised to grow from USD 2.58 billion in 2023 to USD 5.02 billion by 2031, growing at a CAGR of 8.7% during the forecast period (2024-2031).

In order to discriminate between healthy cells and cancer-causing cells, molecular cytogenetics merges the fields of molecular biology and cytogenetics. When it was revealed that typical human cells have 46 chromosomes, human cytogenetics got its start. The study of molecular cytogenetics can be helpful in identifying and treating a variety of malignancies, including brain tumours, haematological malignancies, and other cancer-related precursors. The field's overall focus is on chromosomal evolution, specifically the prevalence, makeup, purpose, and origin of chromosome abnormalities. It consists of a set of procedures known as fluorescence in situ hybridization, or FISH, in which DNA probes are marked with various fluorescent tags in order to see one or more particular areas of the genome.

One of the main drivers propelling the market's expansion is the rising incidence of cancer and other genetic illnesses, as well as the growing geriatric population. The main applications of molecular cytogenetics are the development of future models of disease features and efficient therapeutic approaches. The market expansion is also being aided by the increased use of targeted therapies for the treatment of cancer. To identify cancer stages and give each patient a customised course of treatment, pharmacogenomic biomarker studies also use FISH and Comparative Genomic Hybridization.

Other growth-promoting elements include various technological developments, such as the creation of enhanced consumables, reagents, software, and kits. These developments help produce reproducible, precise, and trustworthy clinical-pathological test outcomes. The market is expected to be further fueled by additional factors, such as notable advancements in healthcare infrastructure and large investments in biomedical research and development.

US Molecular Cytogenetics Market is poised to grow at a sustainable CAGR for the next forecast year.